Skip Navigation Links
Most Viewed: NEJM Most Viewed Articles - Week
Tragedy, Perseverance, and Chance — The Story of CAR-T Therapy9/13/2017 7:00 AM
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer9/8/2017 8:05 AM
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma9/10/2017 7:00 PM
Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes9/12/2017 6:30 PM
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma9/10/2017 8:05 AM
Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis9/11/2017 4:45 AM
Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma9/10/2017 8:05 AM
Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease9/11/2017 4:30 PM
Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke9/13/2017 5:00 PM
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease8/26/2017 11:00 PM
Most Cited: NEJM Most Cited Articles - Recent
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease5/3/2017 5:00 PM
Ebola RNA Persistence in Semen of Ebola Virus Disease Survivors — Preliminary Report10/14/2015 7:00 AM
Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients4/5/2017 5:00 PM
Chimpanzee Adenovirus Vector Ebola Vaccine3/8/2017 4:00 PM
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma3/15/2017 5:00 PM
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes8/16/2017 5:00 PM
Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients4/19/2017 5:00 PM
Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia3/1/2017 4:00 PM
Bioresorbable Scaffolds versus Metallic Stents in Routine PCI6/14/2017 5:00 PM
Autologous Induced Stem-Cell–Derived Retinal Cells for Macular Degeneration3/15/2017 5:00 PM
All contents copyright © 2017 by Nialls Systems